Photocatalytic degradation of antibiotics using a novel Ag/Ag2S/Bi2MoO6 plasmonic p-n heterojunction photocatalyst: Mineralization activity, degradation pathways and boosted charge separation mechanism

Shijie Li,Chunchun Wang,Yanping Liu,Bing Xue,Wei Jiang,Yu Liu,Liuye Mo,Xiaobo Chen

DOI: https://doi.org/10.1016/j.cej.2021.128991

IF: 15.1

2021-07-01

Chemical Engineering Journal

Abstract:A novel Ag/Ag2S/Bi2MoO6 plasmonic p-n heterojunction has been constructed via the in-situ growth of p-type Ag2S nanoparticles on n-type Bi2MoO6 microspheres, followed by the photo-reduction treatment. Simultaneously, the Ag0 loading percentage in the heterojunction could be finely controlled by tuning the photo-reduction time. The optimized Ag/Ag2S/Bi2MoO6 (AAS/BMO-4) manifests the highest photocatalytic performance towards degrading levofloxacin (LEV) and tetracycline hydrochloride (TC), which degradation efficiencies are 87.3% and 92.8%, respectively. Such improvement mechanism could be due to the improved light absorption in the visible-light region induced by localized surface plasmon resonance (LSPR) and the efficient interfacial separation and transport of charge carriers in Ag/Ag2S/Bi2MoO6. The impacts of some key parameters (e.g., various inorganic anions, representative organic substances and various water resources) are systematically investigated. Ag/Ag2S/Bi2MoO6 also exhibits excellent mineralization capability and recycling performance in degrading LEV. Moreover, photo-generated h+, OH, and O2 – are identified as the dominant reactive species accounting for the degradation of antibiotics. The photodegradation pathway of LEV has also been elucidated based on the intermediate identification. Therefore, this study not only reports an innovative plasmonic p-n heterojunction but also the new design of photocatalysts capable of efficiently degrading pharmaceutical antibiotics under visible-light irradiation.

engineering, chemical, environmental

What problem does this paper attempt to address?

The problem this paper attempts to address is the significant threat to ecosystems posed by the accumulation of antibiotics in the environment. Specifically, antibiotics such as Levofloxacin (LEV) and Tetracycline Hydrochloride (TC) are difficult to effectively remove through conventional water treatment technologies (such as filtration, adsorption, and biodegradation) due to their high stability and low biodegradability. Therefore, researchers need to develop new technologies to efficiently remove these antibiotics.

To solve this problem, the authors designed and prepared a novel Ag/Ag₂S/Bi₂MoO₆ plasmonic p-n heterojunction photocatalyst. This catalyst was prepared by in-situ growth of p-type Ag₂S nanoparticles on n-type Bi₂MoO₆ microspheres, followed by photoreduction treatment. The optimized Ag/Ag₂S/Bi₂MoO₆ (AAS/BMO-4) exhibited the highest photocatalytic performance, increasing the degradation efficiency of LEV and TC to 87.3% and 92.8% respectively within 120 minutes.

This study not only reports an innovative plasmonic p-n heterojunction but also proposes a newly designed photocatalyst capable of efficiently degrading pharmaceutical antibiotics under visible light irradiation. By systematically studying the effects of key parameters (such as various inorganic anions, representative organic substances, and different water resources), the authors further validated the practicality and stability of the catalyst. Additionally, the study revealed the main active species generated during the photocatalytic degradation process (such as photogenerated holes, hydroxyl radicals, and superoxide radicals) and the photodegradation pathway of LEV.